World Orphan Drug Congress USA 2018
community download

World Orphan Drug Congress USA Boston Healthcare White Paper

Optimal Pathways to Commercial Success for Orphan Drug Innovators


Boston Healthcare Associates, Inc. (Boston Healthcare) has published a case study ahead of the World Orphan Drug Congress 2018 that highlights some of the unique commercialization challenges faced by orphan drug developers. The case study draws upon Boston healthcare’s experience working with an orphan drug manufacturer to prepare for the launch of a novel drug by developing a reimbursement strategy and identifying evidence requirements in order to support product adoption.


Our case study will assist manufacturers of orphan and ultra-orphan drugs to recognize the varying degrees of influence that key stakeholders and the patient care paradigm have throughout the development and commercialization process, as well as the impact this can have in developing a successful market access strategy.  


To learn more about Boston Healthcare visit their website.

Some quick details

Email Address:*
First name:*
Last name:*
Job Title:*

Remember my details Information

Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

Privacy statement »
Manage your email preferences »

You will be emailed the document as an attachment (551Kb in size)